SMi Source Lesson Anticoagulation: Treatments I

  • SMi Source lesson Anticoagulation: Treatments I has the following microlearning topics

  • 1. Introduction

    2. Overview of Anticoagulation Therapy

    3. Atrial Fibrillation Overview

    4. Atrial Fibrillation Stroke Risk

    5. Risk of Thromboembolism

    6. Guidelines for Anticoagulation Therapy

    7. Knowledge Check: Anticoagulant Prophylaxis

    8. Knowledge Check: 2012 ACCP Guidelines for Antithrombotic Therapy

    9. Knowledge Check: 2011 ACCF/AHA/HRS Recommendations for Antithrombotic Therapy

    10. Venous Thromboembolism (VTE) Prophylaxis

    11. VTE Prevention in Medical Patients

    12. VTE Prevention in Medical Patients: Increased Risk for VTE

    13. ACCP, AAOS, ASRA Compendium of Consensus Recommendations for VTE Prophylaxis

    14. Prevention in Surgical Patients Non-Orthopedic Surgery

    15. Prevention in Surgical Patients Non-Orthopedic Surgery: American College of Chest Physicians (ACCP) Guidelines

    16. Prevention in Surgical Patients and Orthopedic Surgery

    17. Prevention in Surgical Patients and Orthopedic Surgery: American College of Chest Physicians Guidelines

    18. Knowledge Check: ACCP Guidelines

    19. Knowledge Check: Anticoagulant Agents

    20. Venous Thromboembolism Overview

    21. Pulmonary Embolism

    22. Pulmonary Embolism Treatment

    23. Venous Thromboembolism Treatment

    24. Venous Thromboembolism Treatment: Uncomplicated Initial Treatment

    25. Venous Thromboembolism Treatment: Complications or Comorbidities

    26. Venous Thromboembolism Treatment: Complications During Therapy

    27. Venous Thromboembolism Treatment: ACCP Treatment Guidelines

    28. Follow-Up and Secondary Prevention - Duration of Treatment

    29. Follow-Up and Secondary Prevention: Bridging and Perioperative Management

    30. Follow-Up and Secondary Prevention - Chronic Thromboembolic Pulmonary Hypertension

    31. Knowledge Check: Initial Treatment of VTE

    32. Knowledge Check: Contraindications to Anticoagulation

    33. Knowledge Check: Anticoagulants

    34. Standard Anticoagulants

    35. Vitamin K Antagonists (VKAs)

    36. Knowledge Check: Warfarin Dose Adjustment

    37. Knowledge Check: International Normalized Ratio (INR)

    38. Aspirin: Overview

    39. Aspirin: Mechanism of Action

    40. Knowledge Check: Aspirin

    41. Unfractionated Heparin: Overview

    42. Knowledge Check: Prescribing Information for Heparin

    43. Knowledge Check: Complete Blood Cell Count (CBC)

    44. Low-Molecular-Weight Heparin (LMWH)

    45. Low-Molecular-Weight Heparin (LMWH): Dosage and Administration

    46. Knowledge Check: Low-Molecular-Weight Heparins (LMWHs)

    47. Knowledge Check: Enoxaparin and Dalteparin

    48. Fondaparinux: Overview

    49. Knowledge Check: Prescribing Information for Fondaparinux

    50. Knowledge Check: Anticoagulant Mechanism of Action

    51. Standard Agents: Clinical Studies

    52. Vitamin K Antagonists (VKAs): Warfarin

    53. Vitamin K Antagonists (VKAs) Warfarin: Acute Venous Thromboembolism (VTE)

    54. Vitamin K Antagonists (VKAs) Warfarin: ACCP CHEST Guidelines

    55. Vitamin K Antagonists (VKAs) Warfarin: Venous Thromboembolism (VTE)

    56. Knowledge Check: Prevention of DVT in Surgical Patients

    57. Knowledge Check: VTE Recurrence

    58. Knowledge Check: Vitamin K Antagonist (VKA) Anticoagulant Treatment

    59. Aspirin

    60. Knowledge Check: Clinical Benefit of Aspirin

    61. Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparins (LMWHs)

    62. Recurrent Venous Thromboembolism (VTE)

    63. Knowledge Check: LMWH vs. UFH

    64. Fondaparinux: Clinical Studies

    65. Knowledge Check: Fondaparinux

    66. Knowledge Check: Fondaparinux Bleeding Events

    67. Therapeutic Challenges of Antithrombotic Treatment

    68. Vitamin K Antagonists (VKAs): Warfarin Contraindications

    69. Vitamin K Antagonists (VKAs): Warfarin Special Considerations and Drug Interactions

    70. Vitamin K Antagonists (VKAs): Warfarin Monitoring and Warfarin Anticoagulant Reversal

    71. Knowledge Check: Warfarin Warnings and Precautions

    72. Knowledge Check: INR Response

    73. Aspirin: Warnings and Precautions

    74. Aspirin: Anticoagulant Reversal

    75. Knowledge Check: Aspirin Warnings and Precautions

    76. Unfractionated Heparin: Warnings and Precautions

    77. Unfractionated Heparin: Contraindications, Monitoring and Anticoagulation Reversal

    78. Knowledge Check: Unfractionated Heparin Administration

    79. Knowledge Check: Activated Partial Thromboplastin (aPTT)

    80. Enoxaparin and Dalteparin: Boxed Warning

    81. Enoxaparin: Warnings and Precautions

    82. Enoxaparin: Contraindications and Dalteparin: Warnings and Precautions

    83. Dalteparin Contraindications and Laboratory Monitoring

    84. Fondaparinux: Boxed Warning

    85. Fondaparinux: Warnings and Precautions

    86. Fondaparinux: Contraindications, Laboratory Monitoring and Anticoagulant Reversal

    87. Knowledge Check: Boxed Warning

    88. Knowledge Check: Monitoring Low-Molecular-Weight Heparins and Fondaparinux

    89. Knowledge Check: Contraindications to Fondaparinux

    90. Knowledge Check: Reversal Agents

    91. Table of Agents for Review